Delivery Order SPE2DB22D1202-SPE2DB25FVGJ7
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,603.96 on July 29, 2025, for the supply of Remicade 100 mg vials, with a completion date of July 30, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $23,484.87 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 12, 2025. This firm fixed price contract, awarded on August 11, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,024.40, is for the supply of 4,568,093,049 units of Remicade 100 mg vials. The award has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of Remicade 100 mg vials, a specialty brand name medication. The delivery order has a ceiling value of $44,623.83 and a period of performance through March 19, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to...
- This $12,330.24 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,440,341 units of Remicade 100 mg vials, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for the delivery of a comprehensive range of medical commodities to support military treatment...
- This is a $12,330.24 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 100 mg vials of the biologic drug Remicade. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,518.30, is for the delivery of 4,568,139,088 units of the medication Remicade (100 mg vials). The contract is a Firm Fixed Price delivery order, with a performance period extending through May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,926.30, is for the procurement of Remicade 100 mg vials. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, with a ceiling value of $999,999,999 and a period of performance through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,640.36 delivery order is for the supply of Remicade 100 mg vials, a specialty medication used to treat various autoimmune conditions. The contract has a ceiling value of $5,640.36 and an ultimate completion date of September 15, 2022. This award is a child contract under a larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Remicade 100 mg vials, a specialty medication, with a ceiling value of $12,029.28 and a period of performance through February 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVGJ7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,774.78 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling through December 2026. The delivery order was executed on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Remicade is a biologic immunosuppressant medication used to treat autoimmune and inflammatory conditions including rheumatoid arthritis, Crohn's disease, and psoriasis. This delivery order fulfills immediate pharmaceutical supply needs within the Defense Health Agency's medical supply chain, leveraging AmerisourceBergen's role as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The contract was not issued under a set-aside designation, confirming the award through open and unrestricted competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 8/4/25 |